Biobanking of Human Biospecimens (eBook)

Principles and Practice
eBook Download: PDF
2017 | 1st ed. 2017
XII, 239 Seiten
Springer International Publishing (Verlag)
978-3-319-55120-3 (ISBN)

Lese- und Medienproben

Biobanking of Human Biospecimens -
Systemvoraussetzungen
171,19 inkl. MwSt
  • Download sofort lieferbar
  • Zahlungsarten anzeigen
This volume is the first comprehensive text on human biobanking, authored by scientists and regulatory officers who have led the field over the past 10 years. It covers biobanking issues and its importance in advancing the field of research in cancer, cardiovascular, metabolic, and other diseases. Biobanks of human specimens have become the cornerstone for research on human health that harnesses the power of 'omics' technologies to identify biomarkers for disease susceptibility. Biobanks are an essential component of the development of personalized medicine, which relies on the molecular analysis of biospecimens that are truly representative of individuals and of diseases.  Over the past decade, biobanking has been the focus of major investments and developments aimed at developing appropriate infrastructure, methods, networking practice and evidence-based pre-analytical procedures. This volume explores topics including specimen storage, protocol design, specimen collection, pre-analytical processing and preservation, long-term storage, retrieval and separation, and distribution to analytical laboratory platforms.  These activities are extremely complex and are essential for biomedical and biotechnological developments and this text provides critical information about biobanking for the development of future forms of medicine.​ 

Pierre Hainaut, Ph.D., is Professor of Cancer Biology and holds a Chair of Excellence in Translational Cancer Research at University Grenoble-Alpes, France. As head of Molecular Carcinogenesis at the International Agency for Research on Cancer (IARC, World Health Organization, Lyon, France), he has led the development of international standards for biobanking in the fields of molecular epidemiology and pathology, and has been involved in many projects implementing biomarkers in international molecular epidemiological studies in Africa, Asia or Latin America. Currently, he is the Director of the Institute for Advanced Biosciences, a joint research center of the French National Institute of Health and Medical Research (INSERM), National Center for Scientific Research (CNRS) and Université Grenoble-Alpes, dedicated to Epigenetics, Chronic Diseases and Cancer. He is also responsible for Molecular Diagnosis of Cancer at the University Hospital of Grenoble-Alpes, France. His research focuses on TP53 mutations and on biomarkers of transition from chronic diseases to cancer.

Jim Vaught, Ph.D., spent 14 years at the U.S. National Cancer Institute (NCI), most recently as the Chief of the Biorepositories and Biospecimen Research Branch (BBRB) in the Cancer Diagnosis Program.   He's one of the founding members of the International Society for Biological & Environmental Repositories (ISBER) and was its second President. He has provided biobanking consulting services to a variety of​ ​ international​ organizations, ​and​ serves on a number of biobank advisory groups.  He was Senior Editor for Biospecimens and Biorepositories for the AACR journal Cancer Epidemiology, Biomarkers and Prevention and is the  Editor-in-Chief of Biopreservation and Biobanking, the official journal of ISBER.  He is currently a Senior Research Fellow at the International Prevention Research Institute (Lyon).  Dr. Vaught is the immediate Past-President of ISBER and a member of the Board of Directors.  

Kurt Zatloukal, MD, is Professor of Pathology at the Medical University of Graz. He coordinated the preparatory phase of a European biobanking and biomolecular resources research infrastructure (BBMRI) within the 7th EU framework programme, and is the National Node Director of BBMRI. His research fields are molecular pathology of liver diseases and cancer, and the development of biobanking technologies.

Markus Pasterk is Administrative Director of BBMRI-ERIC, the pan-European Research Infrastructure for Biobanking and Biomolecular Resources with Headquarters in Graz, Austria. Before that he was Chief Operating Officer and Vice President/Science, at the International Prevention Research Institute in Lyon, France and Scientific Coordinator of the International Agency for Research of Cancer in Lyon, France. He is an expert in research and E&T management.<

Pierre Hainaut, Ph.D., is Professor of Cancer Biology and holds a Chair of Excellence in Translational Cancer Research at University Grenoble-Alpes, France. As head of Molecular Carcinogenesis at the International Agency for Research on Cancer (IARC, World Health Organization, Lyon, France), he has led the development of international standards for biobanking in the fields of molecular epidemiology and pathology, and has been involved in many projects implementing biomarkers in international molecular epidemiological studies in Africa, Asia or Latin America. Currently, he is the Director of the Institute for Advanced Biosciences, a joint research center of the French National Institute of Health and Medical Research (INSERM), National Center for Scientific Research (CNRS) and Université Grenoble-Alpes, dedicated to Epigenetics, Chronic Diseases and Cancer. He is also responsible for Molecular Diagnosis of Cancer at the University Hospital of Grenoble-Alpes, France. His research focuses on TP53 mutations and on biomarkers of transition from chronic diseases to cancer.Jim Vaught, Ph.D., spent 14 years at the U.S. National Cancer Institute (NCI), most recently as the Chief of the Biorepositories and Biospecimen Research Branch (BBRB) in the Cancer Diagnosis Program.   He’s one of the founding members of the International Society for Biological & Environmental Repositories (ISBER) and was its second President. He has provided biobanking consulting services to a variety of​ ​ international​ organizations, ​and​ serves on a number of biobank advisory groups.  He was Senior Editor for Biospecimens and Biorepositories for the AACR journal Cancer Epidemiology, Biomarkers and Prevention and is the  Editor-in-Chief of Biopreservation and Biobanking, the official journal of ISBER.  He is currently a Senior Research Fellow at the International Prevention Research Institute (Lyon).  Dr. Vaught is the immediate Past-President of ISBER and a member of the Board of Directors.  Kurt Zatloukal, MD, is Professor of Pathology at the Medical University of Graz. He coordinated the preparatory phase of a European biobanking and biomolecular resources research infrastructure (BBMRI) within the 7th EU framework programme, and is the National Node Director of BBMRI. His research fields are molecular pathology of liver diseases and cancer, and the development of biobanking technologies.Markus Pasterk is Administrative Director of BBMRI-ERIC, the pan-European Research Infrastructure for Biobanking and Biomolecular Resources with Headquarters in Graz, Austria. Before that he was Chief Operating Officer and Vice President/Science, at the International Prevention Research Institute in Lyon, France and Scientific Coordinator of the International Agency for Research of Cancer in Lyon, France. He is an expert in research and E&T management.

.- 1. 20 years of biobanking: dawning or a new era (Volume Editors) .-  SECTION 1: BIOBANKS IN PRACTICE.- 2. Principles of cryo-preservation-Allison Hubel (University of Minnesota).- 3. Biobank design and infrastructure-A. Zaayenga (SmarterLab Inc).- 4. Minimal standards for biobank annotations-H.M. Moore (National Cancer Institute).- 5. Biobank governance and sustainability- M. Pasterk (IPRI, France).- 6. Biobanking in low resource contexts-R. Lawlor (University of Verona).- 7. Biosafety and biosecurity -G. D’Agnolo (Italian National Committee on Biosafety, Biotechnology and Life Sciences).- 8. Quality assurance and quality control in Biobanking- Di Donato (INSERM, France).- 9. Biocomputing for biobanks-P. Fearn (University of Washington).- 10.   Ethical and societal challenges for biobanks-Jane Kay (INSERM, France).- SECTION 2: TYPES OF BIOBANKS.- 11. Disease-oriented biobanks: from pathology archives to personalized medicine-Peter Riegman (Erasmus University).- 12. Biobanking for molecular epidemiology- J.Dillner (Helmoltz, Munich). .- 13. Biobanking for biomarker discovery-  Jim Vaught (National Cancer Institute).- 14.   Biobanking in clinical trials- G. Golfinopoulos (EORTC, Belgium).- 15. Industrial Biobanks-(To Be Defined).  .- SECTION 3: NETWORKING BIOBANKS.- 16. International biobank networks: the P3G experience-I. Fortier (McGill University).- 17. Networking Biobanks throughout Europe- KurtEero Vuorio (INSERM, France).- 18.   Biobanking networks through 5 continents  -R. Hewitt, N.  Zeps.- 19.   Driving international convergence through evidence-based standards (Volume Editors). .- 20. National Networking – the case of Spain- Morente Manuel  (CNIO, Madrid).- SECTION 4: The Future of Biobanking.- 21. Training biobankers for the 21st century-E. Gormally (Fac Catholique, France).- 22.   The Science of Biobanking and biospecimen research- Jim Vaught (National Cancer Institute).- 23.   Economics of Biobanking-Jim Vaught (National Cancer Institute).- 24.   Meeting Tomorrow’s Challenges: Biobanking for All (Volume Editors).​

Erscheint lt. Verlag 6.6.2017
Zusatzinfo XII, 239 p. 20 illus., 16 illus. in color.
Verlagsort Cham
Sprache englisch
Themenwelt Medizin / Pharmazie Medizinische Fachgebiete
Medizin / Pharmazie Studium
Schlagworte Biobank infrastructure • Biobanks • Biomarkers • Cryo-preservation • research management
ISBN-10 3-319-55120-5 / 3319551205
ISBN-13 978-3-319-55120-3 / 9783319551203
Haben Sie eine Frage zum Produkt?
PDFPDF (Wasserzeichen)
Größe: 3,9 MB

DRM: Digitales Wasserzeichen
Dieses eBook enthält ein digitales Wasser­zeichen und ist damit für Sie persona­lisiert. Bei einer missbräuch­lichen Weiter­gabe des eBooks an Dritte ist eine Rück­ver­folgung an die Quelle möglich.

Dateiformat: PDF (Portable Document Format)
Mit einem festen Seiten­layout eignet sich die PDF besonders für Fach­bücher mit Spalten, Tabellen und Abbild­ungen. Eine PDF kann auf fast allen Geräten ange­zeigt werden, ist aber für kleine Displays (Smart­phone, eReader) nur einge­schränkt geeignet.

Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen dafür einen PDF-Viewer - z.B. den Adobe Reader oder Adobe Digital Editions.
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen dafür einen PDF-Viewer - z.B. die kostenlose Adobe Digital Editions-App.

Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.

Mehr entdecken
aus dem Bereich
Hämatologie und Internistische Onkologie

von Dietmar P. Berger; Monika Engelhardt; Justus Duyster

eBook Download (2023)
Ecomed (Verlag)
99,99